Literature DB >> 2649357

Management of hypertension in actively exercising patients. Implications for drug selection.

D Klaus1.   

Abstract

In general, rises in systolic blood pressure to over 200 mm Hg during exercise with a workload of 100W are regarded as pathological. Excessive exercise blood pressure values are to be expected in principle in all hypertensives. However, there are so far no generally accepted criteria for diagnosis of isolated systolic exercise hypertension (with normal values of resting blood pressure). The incidence of isolated systolic exercise hypertension is estimated to be about 10% of a selected population. In patients with excessive rises in blood pressure during exercise who want to engage actively in sport, general measures (reduction of obesity, restriction of alcohol and salt intake) and endurance training should be recommended initially. For endurance training, sporting activities that involve dynamic exercise are to be recommended (walking, running, mountain hiking, cycling, swimming, cross-country skiing). Activities involving isometric exercise (rowing, diving, tennis) and sport of a competitive nature are not suitable. In moderately severe and severe hypertension (diastolic blood pressure values in excess of 105 mm Hg), sporting activities and endurance training are contraindicated. If the exercise blood pressure values cannot be lowered below 220 mm Hg with the general measures mentioned, pharmacotherapy is to be considered. The drugs of choice for suppressing excessive rises in blood pressure during exercise are beta-blockers. In this group, beta 1-blockers are to be preferred to non-selective beta-blockers because of the metabolic neutrality of the former. beta-Blockers without intrinsic sympathomimetic activity (ISA) lower the blood pressure-pulse rate product more effectively than beta-blockers with ISA. Alternatively, calcium antagonists of the verapamil type and ACE inhibitors can be employed.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2649357     DOI: 10.2165/00003495-198937020-00008

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  22 in total

1.  Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoreceptor blockade by labetalol.

Authors:  G Koch
Journal:  Br Heart J       Date:  1979-02

Review 2.  Habitual physical activity, training, and blood pressure in normo- and hypertension.

Authors:  R Fagard
Journal:  Int J Sports Med       Date:  1985-04       Impact factor: 3.118

3.  Assessment of blood pressure response during ergometric work in normotensive and hypertensive patients.

Authors:  I W Franz
Journal:  Acta Med Scand Suppl       Date:  1982

4.  Early prediction of hypertension using exercise blood pressure.

Authors:  N V Wilson; B M Meyer
Journal:  Prev Med       Date:  1981-01       Impact factor: 4.018

5.  Relationship between level of blood pressure measured casually and by portable recorders and severity of complications in essential hypertension.

Authors:  M Sokolow; D Werdegar; H K Kain; A T Hinman
Journal:  Circulation       Date:  1966-08       Impact factor: 29.690

6.  Failure of anti-hypertensive drugs to control blood pressure rise with isometric exercise in hypertension.

Authors:  J A O'Hare; D J Murnaghan
Journal:  Postgrad Med J       Date:  1981-09       Impact factor: 2.401

7.  An evaluation of the effect on resting and exercise blood pressure of some first line treatments in hypertension.

Authors:  A R Lorimer; M B Barbour; T D Lawrie
Journal:  Ann Clin Res       Date:  1983

8.  Short- and long-term (six-year) hemodynamic effects of labetalol in essential hypertension.

Authors:  P Lund-Johansen
Journal:  Am J Med       Date:  1983-10-17       Impact factor: 4.965

9.  [Effect of the alpha 1-receptor blocker prazosin and the beta 1-receptor blocker acebutolol and their combination on blood pressure and pressure rate product. Ergometric studies of hypertensive patients].

Authors:  I W Franz
Journal:  Z Kardiol       Date:  1984-01

Review 10.  Aspects of hormonal regulation of lipolysis during exercise: effects of chronic beta-receptor blockade.

Authors:  I W Franz; F W Lohmann; G Koch; H J Quabbe
Journal:  Int J Sports Med       Date:  1983-02       Impact factor: 3.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.